131 related articles for article (PubMed ID: 25743819)
1. Adoptive immunotherapy for small cell lung cancer by expanded activated autologous lymphocytes: a retrospective clinical analysis.
Zhang GQ; Li F; Sun SJ; Hu Y; Wang G; Wang Y; Cui XX; Jiao SC
Asian Pac J Cancer Prev; 2015; 16(4):1487-94. PubMed ID: 25743819
[TBL] [Abstract][Full Text] [Related]
2. Prolonged overall survival in gastric cancer patients after adoptive immunotherapy.
Zhang GQ; Zhao H; Wu JY; Li JY; Yan X; Wang G; Wu LL; Zhang XG; Shao Y; Wang Y; Jiao SC
World J Gastroenterol; 2015 Mar; 21(9):2777-85. PubMed ID: 25759549
[TBL] [Abstract][Full Text] [Related]
3. Immune modulation and safety profile of adoptive immunotherapy using expanded autologous activated lymphocytes against advanced cancer.
Sun Z; Shi L; Zhang H; Shao Y; Wang Y; Lin Y; Li X; Bai C
Clin Immunol; 2011 Jan; 138(1):23-32. PubMed ID: 21041120
[TBL] [Abstract][Full Text] [Related]
4. Adoptive immunotherapy for non-small cell lung cancer by NK and cytotoxic T lymphocytes mixed effector cells: retrospective clinical observation.
Zhang G; Zhao H; Wu J; Li J; Xiang Y; Wang G; Wu L; Jiao S
Int Immunopharmacol; 2014 Aug; 21(2):396-405. PubMed ID: 24881900
[TBL] [Abstract][Full Text] [Related]
5. The prognostic role of circulating CD8
An N; Wang H; Jia W; Jing W; Liu C; Zhu H; Yu J
J Transl Med; 2019 Dec; 17(1):402. PubMed ID: 31796037
[TBL] [Abstract][Full Text] [Related]
6. Peripheral-type small cell lung cancer is associated with better survival and higher frequency of interstitial lung disease.
Kanaji N; Sakai K; Ueda Y; Miyawaki H; Ishii T; Watanabe N; Kita N; Kadota K; Kadowaki N; Bandoh S
Lung Cancer; 2017 Jun; 108():126-133. PubMed ID: 28625624
[TBL] [Abstract][Full Text] [Related]
7. Prognostic assessment in patients with newly diagnosed small cell lung cancer brain metastases: results from a real-life cohort.
Steindl A; Schlieter F; Klikovits T; Leber E; Gatterbauer B; Frischer JM; Dieckmann K; Widhalm G; Zöchbauer-Müller S; Hoda MAR; Preusser M; Berghoff AS
J Neurooncol; 2019 Oct; 145(1):85-95. PubMed ID: 31456143
[TBL] [Abstract][Full Text] [Related]
8. Lung immune prognostic index as a prognostic factor in patients with small cell lung cancer.
Sonehara K; Tateishi K; Komatsu M; Yamamoto H; Hanaoka M
Thorac Cancer; 2020 Jun; 11(6):1578-1586. PubMed ID: 32286017
[TBL] [Abstract][Full Text] [Related]
9. Autologous cytokine-induced killer cell therapy in lung cancer patients: a retrospective study.
Zhang J; Zhu L; Du H; He X; Yin Y; Gu Y; Liu L; Lu K; Guo R; Liu P; Shu Y
Biomed Pharmacother; 2015 Mar; 70():248-52. PubMed ID: 25776508
[TBL] [Abstract][Full Text] [Related]
10. Are pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer?
Deng M; Ma X; Liang X; Zhu C; Wang M
Oncotarget; 2017 Jun; 8(23):37200-37207. PubMed ID: 28380461
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy in combination with cytokine-induced killer cell transfusion: An effective therapeutic option for patients with extensive stage small cell lung cancer.
Huang J; Kan Q; Lan ; Zhao X; Zhang Z; Yang S; Li H; Wang L; Xu L; Cheng Z; Zhang Y
Int Immunopharmacol; 2017 May; 46():170-177. PubMed ID: 28292730
[TBL] [Abstract][Full Text] [Related]
12. Effect of Thoracic Radiotherapy Timing and Fractionation on Survival in Nonmetastatic Small Cell Lung Carcinoma.
Wong AT; Rineer J; Schwartz D; Becker D; Safdieh J; Osborn V; Schreiber D
Clin Lung Cancer; 2017 Mar; 18(2):207-212. PubMed ID: 27686970
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of factors associated with loco-regional failure and survival in limited disease small cell lung cancer patients treated with chemoradiotherapy.
Winther-Larsen A; Hoffmann L; Moeller DS; Khalil AA; Knap MM
Acta Oncol; 2015; 54(9):1574-81. PubMed ID: 26203924
[TBL] [Abstract][Full Text] [Related]
14. Survival and pretreatment prognostic factors for extensive-stage small cell lung cancer: A comprehensive analysis of 358 patients.
Huang LL; Hu XS; Wang Y; Li JL; Wang HY; Liu P; Xu JP; He XH; Hao XZ; Jiang PD; Liu YT; Luo J; Zhou SY; Wang JW; Yang JL; Qin Y; Yuan P; Lin L; Shi YK
Thorac Cancer; 2021 Jul; 12(13):1943-1951. PubMed ID: 33969619
[TBL] [Abstract][Full Text] [Related]
15. Neuron-specific enolase and response to initial therapy are important prognostic factors in patients with small cell lung cancer.
Zhou M; Wang Z; Yao Y; Zhou H; Liu M; Sun J
Clin Transl Oncol; 2017 Jul; 19(7):865-873. PubMed ID: 28127669
[TBL] [Abstract][Full Text] [Related]
16. Additional radiation boost to whole brain radiation therapy may improve the survival of patients with brain metastases in small cell lung cancer.
Sun H; Xu L; Wang Y; Zhao J; Xu K; Qi J; Yuan Z; Zhao L; Wang P
Radiat Oncol; 2018 Dec; 13(1):250. PubMed ID: 30563554
[TBL] [Abstract][Full Text] [Related]
17. Cellular immunotherapy as maintenance therapy prolongs the survival of the patients with small cell lung cancer.
Ding X; Cao H; Chen X; Jin H; Liu Z; Wang G; Cai L; Li D; Niu C; Tian H; Yang L; Zhao Y; Li W; Cui J
J Transl Med; 2015 May; 13():158. PubMed ID: 25968637
[TBL] [Abstract][Full Text] [Related]
18. Prognostic role of patient gender in limited-disease small-cell lung cancer treated with chemoradiotherapy.
Roengvoraphoj O; Eze C; Niyazi M; Li M; Hildebrandt G; Fietkau R; Belka C; Manapov F
Strahlenther Onkol; 2017 Feb; 193(2):150-155. PubMed ID: 27853828
[TBL] [Abstract][Full Text] [Related]
19. High pretreatment neutrophil-lymphocyte ratio predicts recurrence and poor prognosis for combined small cell lung cancer.
Shao N; Cai Q
Clin Transl Oncol; 2015 Oct; 17(10):772-8. PubMed ID: 26243392
[TBL] [Abstract][Full Text] [Related]
20. The value of prognostic factors in Chinese patients with small cell lung cancer: A retrospective study of 999 patients.
Hong X; Xu Q; Yang Z; Wang M; Yang F; Gao Y; Zhou F; Wang L; Liu B; Chen G
Clin Respir J; 2018 Feb; 12(2):433-447. PubMed ID: 27460525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
